We are pleased to announce a launch of a new website providing resources for good reporting of health research. The resources are aimed at researchers (authors of research articles), journal editors, peer reviewers, and developers of reporting guidelines.
The most important website feature is a collection of reporting guidelines that includes:
CONSORT Statement (for reporting randomised controlled trials)
QUOROM, recently renamed PRISMA (for reporting systematic reviews and meta-analyses of randomised trials)
STROBE Statement (for reporting observational … Continue Reading
The CONSORT executive and staff met in Oxford, UK, for a three-day meeting in mid-September 2007 to discuss current issues concerning CONSORT and to work on updating the 2001 CONSORT Statement.
Revision of the CONSORT Statement
One of the highest priority agenda items was the revision of the CONSORT checklist. Since the larger CONSORT Group meeting in Montebello, Canada, in January 2007, the executive have been working on revising the CONSORT checklist, taking into account the suggestions of the Group. After many versions, a draft was circulated to the wider Group in August 2007. At the … Continue Reading
Good reporting of trials (CONSORT) and observational studies (STROBE) [public symposium]
PRESENTERS: David Moher and Doug AltmanEVENT: Systematic Reviews and Meta-Analyses coursesLOCATION: Copenhagen, DenmarkDATE: 17 August 2007
Understanding and following CONSORT guidelines [workshop]
PRESENTER: Doug AltmanEVENT: International Clinical Trials SymposiumLOCATION: Sydney, AustraliaDATE: 23 September 2007
The latest on CONSORT (Consolidated Standards of Reporting Trials)
PRESENTER: Doug AltmanEVENT: International Clinical Trials SymposiumLOCATION: Sydney, Australia& … Continue Reading
Doug Altman has won the annual Award for Meritorious Achievement, the highest award from the Council of Scientific Editors (CSE), for his work to improve the standards of reporting of clinical research.High quality research must involve clear and transparent reporting that can be judged and assessed by other people, including peer review panels. Although this seems like a basic idea, there is a substantial amount evidence that shows that clear and transparent reporting of research does not routinely happen. In efforts to increase the quality of research, reporting guidelines can help … Continue Reading
A number of empirical studies have highlighted the need for improvements in the reporting of conference abstracts and the abstracts of journal articles presenting the results of randomized trials (215). Currently, the CONSORT Statement provides limited guidance about abstracts and, while it encourages the use of structured abstracts, this is not a formal requirement.
We are extending the current CONSORT Statement to develop a checklist of essential items to be included in any conference or journal abstract reporting the results of a randomized trial.
In developing this checklist, we … Continue Reading
Non-pharmacological Treatments (NPT) cover a wide range of interventions including surgery, technical procedures (e.g., angioplasty), implanted devices (e.g., pacemaker), non-implantable devices, rehabilitation, physiotherapy, behavioural therapy, and psychotherapy.
Assessing NPT in randomized controlled trials raises specific issues linked to the complexity of the interventions, the influence of care providers and centres' volume, and the difficulties of blinding. However, the quality of reporting these issues in NPT trials raises some concern and is a barrier to adequately appraise the … Continue Reading
The CONSORT Group met in Montebello, Canada in January 2007; the participants were 28 invited investigators, journal editors and other experts from around the world. The aims of the three-day meeting were to revise the 2001 CONSORT Statement, to develop a CONSORT extension for trials reported in journal and conference abstracts, and to discuss more general CONSORT issues.
Based on the emerging evidence that was presented, a number of modifications to the CONSORT checklist and Explanation and Elaboration document (E&E) were deliberated. On the … Continue Reading
We are very pleased to announce that in 2006 the UK National Co-ordinating Centre for Research and Methodology (NCCRM) awarded a five-year grant to the CONSORT Group for part of the intellectual support needed for CONSORT activities.
The grant provides funding for two part-time positions - a Coordinator in Ottawa, Canada, and a Researcher in Oxford, UK. These posts aim to provide the necessary support to the CONSORT executive, who until now have had no explicit research or administrative asistance.
The NCCRM grant has also helped to fund the& … Continue Reading
To keep up with the growing complexity and increasing impact of the CONSORT Statement in the world-wide medical research field, the CONSORT Group is excited to announce the launch of the new CONSORT website, hoping to further its impact on improving the quality of clinical research.
Since 1996, when the original CONSORT Statement (43) was published, CONSORT has branched out into different aspects beyond the initial CONSORT checklist and flow diagram. For instance, when the CONSORT Statement was revised in 2001 (56-58), it was accompanied by the publication of the& … Continue Reading